On Jul. 6, 2021, the World Health Organization announced updated patient care guidelines to include interleukin-6 receptor blockers,…
On Jul. 6, 2021, Dynavax Technologies and Biological E announced the execution of a commercial supply agreement of…
On Jul. 5, 2021, CerTest Biotec and BD announces addition of saliva to the CE Marked VIASURE SARS-CoV-2…
On Jul. 2, 2021, the National Institutes of Health funding five additional projects to identify ways of safely…
On Jul. 2, 2021, the Food and Drug Administration (FDA) authorized the use, under the emergency use authorization…
On Jul. 1, 2021, Moderna confirmed that following the European Medicines Agency’s (EMA) Committee for Human Medicines (CHMP)…
On Jul. 1, 2021, HDT Bio announced the U.S. Food and Drug Administration had reviewed the companyï¾’s Investigational…
On Jun. 30, 2021, Atea Pharmaceuticals announced positive interim results from the global Phase 2 study evaluating AT-527…
On Jun. 30, 2021, the National Institutes of Health announced a highly anticipated study that compared rapid antigen…
On Jun. 30, 2021, CureVac announced results from the final analysis of its 40,000 subject international pivotal Phase…
On Jun. 30, 2021, the National Institutes of Health announced that two U.S. Phase 1 clinical trials of…
On Jun. 30, 2021, following a 70-year effort, China was awarded a malaria-free certification from the World Health…
On Jun. 30, 2021, XPhyto announced that it had signed a master supply agreement with Beovita and Tackleberries,…
On Jun. 30, 2021, Novavax announced the publication of results from the final analysis of a pivotal Phase…
On Jun. 30, 2021, SIGA Technologies announced that it had provided TPOXX (tecovirimat) to Liverpool University Hospitals NHS…
On Jun. 30, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Clover…
On Jun. 29, 2021, Rigel Pharma announced that fostamatinib, the Company’s novel oral spleen tyrosine kinase (SYK) inhibitor,…
On Jun. 29, 2021, the National Institutes of Health announced that an adjuvant developed with its funding had…
On Jun. 29, 2021, Paratek Pharmaceuticals announced it had delivered the first procurement of NUZYRA to the Biomedical…
On Jun. 29, 2021, Moderna announced new results from in vitro neutralization studies of sera from individuals vaccinated…
On Jun. 29, 2021, Moderna announced that the government of India had issued a registration certificate and a…
On Jun. 29, 2021, Altimmune announced phase 1 AdCOVID clinical trial data that showed AdCOVID appeared to be…
On Jun. 29, 2021, VBI Vaccines announced positive Phase 1 data from its Phase 1/2 trial of the…
On Jun. 28, 2021, the University of Oxford in partnership with AstraZeneca began vaccinations for a new phase…
On Jun. 28, 2021, researchers running the University of Oxford-led Com-COV study reported that alternating doses of the…
On Jun. 28, 2021, Meridian Bioscience announced that it had re-submitted its application for Emergency Use Authorization (EUA)…
Cast of Characters: Jay Inslee, Governor, Washington | Gavin Newsom, Governor, California | Doug Ducey, Governor, Arizona |…
On Jun. 25, 2021, Roche announced that the Food and Drug Administration (FDA) has issued an Emergency Use…
On Jun. 24, 2021, researchers from the University of Oxford released their findings about the so-called ﾑcorrelates of…
On Jun. 23, 2021, the National Institutes of Health announced that an observational study had begun to evaluate…